Navigation Links
Halt Medical Announces CMS Assignment of Ambulatory Payment Classification for RF Ablation of Uterine Fibroids
Date:12/2/2013

LIVERMORE, Calif., Dec. 2, 2013 /PRNewswire/ -- Halt Medical is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has established a new Ambulatory Payment Classification (APC) for Radiofrequency (RF) Ablation of Uterine Fibroids. The APC 174 carries a reimbursement rate of $8,593.40 for the single-use handpiece and the hospital's other operating costs related to the procedure. The physician reports services under the newly created CPT code – 0336T, and is reimbursed separately. The APC and CPT codes will become effective January 1, 2014. 

(Logo: http://photos.prnewswire.com/prnh/20131202/LA26268LOGO)

"The assignment of an APC recognizes that RF ablation with the Acessa System is an important option for women suffering from uterine fibroids," said Jayne A. Little, Halt Medical's VP of Global Healthcare Economics. Jeffrey M. Cohen, CEO of Halt Medical added, "Today's decision further validates the Acessa Procedure in the treatment algorithm of symptomatic uterine fibroids." David J. Levine, MD has shared, "By recognizing this procedure and establishing a fee schedule, I'm able to continue to offer Acessa as a viable treatment option for my patients. They're the real winners here."

The Acessa Procedure is a minimally invasive laparoscopic procedure that delivers radiofrequency energy to destroy the fibroids. After treatment, the fibroid is re-absorbed by the surrounding tissue. Acessa allows the surgeon to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and enjoy a rapid return to normal activities. The Acessa System is now available at leading medical centers throughout the U.S.

About Halt Medical, Inc.

Founded in 2004, Halt Medical is a medical device innovator focused on establishing a new standard of care for women with symptomatic uterine fibroids. The Company has developed and launched the Acessa System and Procedure, using radiofrequency energy to destroy uterine fibroids. The results of both U.S. and international trials have led to the clearance of the product by the FDA for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. The Acessa System also has regulatory approval to treat symptomatic uterine fibroids in the European Union, Canada, and Mexico. The Company is located in Brentwood, CA. For information about the Acessa System, please visit www.haltmedical.com. To connect with Halt Medical on Facebook visit www.facebook.com/acessasystem or on Twitter at www.twitter.com/acessasystem.  

WEBSITE:  http://www.haltmedical.com  


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... 2020 , ... NeoTract, a wholly owned subsidiary of Teleflex ... announced that Jayant Uberoi, MD, Chesapeake Urology in Baltimore MD, has been designated ... achieved a high level of training and experience with the UroLift® System and ...
(Date:2/19/2020)... ... , ... Aspire Regenerative, a leader in offering therapies that restore healthy tissues ... weight-loss event on March 1, 2020. It will take place from 10:30 a.m. to ... During the event, physicians and pharmacists will lead an informative and insightful discussion on ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... The Team ... equal access to medicine for everyone affected by diabetes, announced a partnership with VeloCity, ... , The third annual VeloCity event takes place on May 2nd and begins ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Medical Training announced its next ... will learn how to perform injections for all large and small joints along with ... from online videos. The best opportunity is to perform injections in a supervised setting. ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... a grant of $10,000.00 from the Doug Flutie, Jr. Foundation for Autism. The ... students with autism. , The physical fitness program will include the hiring of ...
(Date:2/19/2020)... ... February 19, 2020 , ... MedTech IGNITE Expands Steering ... to Participate in 2020 Cohort , The Massachusetts Medical Device Industry Council ( ... accepting applications from startup founders and CEOs to participate in the 2020 IGNITE ...
(Date:2/19/2020)... ... February 19, 2020 , ... SEAL SHIELD, LLC - ... result of healthcare-acquired infections (HAIs.) According to The Centers for Disease Control (CDC), 80% ... large amount of screens that are now acting as an extension of people’s hands, ...
(Date:2/15/2020)... ... February 14, 2020 , ... UMF Corporation , ... Hospital , a member of Prisma Health, providing a comprehensive PCPLUS ... was able to cut its monthly laundry management costs in half, support infection ...
Breaking Medicine News(10 mins):